Division of Genetic Medicine and Clinical Pharmacology Archive — Page 8 of 12
-
May 25, 2022
Study seeks to improve gender equity for liver transplantation waiting list
Women who need a liver transplant are more likely to spend more time on a waiting list, become too sick for transplant or die compared to men. To improve equity, a recently published Vanderbilt-led study suggests a sex adjustment to criteria for MELD (model for end-stage liver disease), which determines allocation of transplanted livers. -
May 5, 2022
Gene network linked to Type 2 diabetes
Vanderbilt researchers used a novel analytical approach to identify a network of genes associated with Type 2 diabetes, including 31 genes that had not previously been associated with the disease. -
April 28, 2022
Studies combine genetic testing, electronic health records to find undiagnosed diseases
Combining genetic testing with information from electronic health records revealed undiagnosed heart rhythm disorders and new conditions associated with inherited cancer gene mutations. -
April 14, 2022
VUMC research team receives $1 million grant from AHA to study impact of long-COVID on heart
A research team led by Cyndya Shibao, MD, MSCI, associate professor of Medicine at Vanderbilt University Medical Center (VUMC), has received a three-year, $1-million grant from the American Heart Association to study long-term effects of COVID-19 on the heart and cardiovascular system. -
April 11, 2022
Peptides promote AFib arrhythmia
Peptide oligomers have detrimental metabolic effects and cause pro-arrhythmic electrophysiological changes in heart atria, suggesting they may contribute to atrial fibrillation. -
March 17, 2022
U.S. precision medicine research program releases genomic data
The All of Us Research Program released an initial large batch of genomic data on its cloud-based research platform, the Researcher Workbench, including whole genome sequences of 98,600 research participants and genotype data from 165,200 participants. -
February 24, 2022
VUMC researchers find clue to drug-induced arrhythmias
Vanderbilt University Medical Center researchers have made a fundamental discovery about how the heart compensates for genetic variations that otherwise could trigger abnormal and potentially fatal heart rhythms.